QuVa Pharma, Inc.: fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.1%
Recall reason: Lack of Assurance of Sterility. Recalled by QuVa Pharma, Inc.. Distribution: U.S. Nationwide. Classification (Class II — potential health risk). Affected lots/NDC/dates: Lots: 10140259, 10140539, 10140687, 10140688; Exp 04/24/2025. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report